{"Title": "Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction\u2014Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial", "Year": 2020, "Source": "Am. Heart J.", "Volume": "224", "Issue": null, "Art.No": null, "PageStart": 129, "PageEnd": 137, "CitedBy": 2, "DOI": "10.1016/j.ahj.2020.01.012", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084081354&origin=inward", "Abstract": "\u00a9 2020 Elsevier Inc.Background: Adverse cardiac remodeling is a major risk factor for the development of post myocardial infarction (MI) heart failure (HF). This study investigates the effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute ST-segment-elevation myocardial infarction (STEMI). Methods: In this double-blind, randomized, placebo-controlled trial patients with first STEMI were eligible. To preferentially enrich patients at high risk of adverse remodeling, main inclusion criteria were a left-ventricular ejection fraction (LVEF) \u226445% and an infarct size >10% on day 5 to 9 post MI as measured by cardiac MRI. Patients were then randomized to 6 months treatment with either 25 mg fulacimstat (n = 54) or placebo (n = 53) twice daily on top of standard of care starting day 6 to 12 post MI. The changes in LVEF, LV end-diastolic volume index (LVEDVI), and LV end-systolic volume index (LVESVI) from baseline to 6 months were analyzed by a central blinded cardiac MRI core laboratory. Results: Fulacimstat was safe and well tolerated and achieved mean total trough concentrations that were approximately tenfold higher than those predicted to be required for minimal therapeutic activity. Comparable changes in LVEF (fulacimstat: 3.5% \u00b1 5.4%, placebo: 4.0% \u00b1 5.0%, P = .69), LVEDVI (fulacimstat: 7.3 \u00b1 13.3 mL/m2, placebo: 5.1 \u00b1 18.9 mL/m2, P = .54), and LVESVI (fulacimstat: 2.3 \u00b1 11.2 mL/m2, placebo: 0.6 \u00b1 14.8 mL/m2, P = .56) were observed in both treatment arms. Conclusion: Fulacimstat was safe and well tolerated in patients with left-ventricular dysfunction (LVD) after first STEMI but had no effect on cardiac remodeling.", "AuthorKeywords": null, "IndexKeywords": ["Chymases", "Double-Blind Method", "Female", "Heart Failure", "Heart Ventricles", "Humans", "Magnetic Resonance Imaging, Cine", "Male", "Middle Aged", "ST Elevation Myocardial Infarction", "Stroke Volume", "Treatment Outcome", "Ventricular Function, Left", "Ventricular Remodeling"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85084081354", "SubjectAreas": [["Cardiology and Cardiovascular Medicine", "MEDI", "2705"]], "AuthorData": {"35332227300": {"Name": "Duengen H.D.", "AuthorID": "35332227300", "AffiliationID": "60026245", "AffiliationName": "Department of Internal Medicine, Cardiology, Charit\u00e9-Universitaetsmedizin"}, "7202933074": {"Name": "Kim R.J.", "AuthorID": "7202933074", "AffiliationID": "60005200, 60113147", "AffiliationName": "Duke Cardiovascular Magnetic Resonance Center, Duke University Medical Center"}, "7004143560": {"Name": "Zahger D.", "AuthorID": "7004143560", "AffiliationID": "60030184, 60027161", "AffiliationName": "Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev"}, "57216613962": {"Name": "Shimony A.", "AuthorID": "57216613962", "AffiliationID": "60030184, 60027161", "AffiliationName": "Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev"}, "25321090500": {"Name": "Orvin K.", "AuthorID": "25321090500", "AffiliationID": "60022119", "AffiliationName": "Rabin Medical Center - Beilinson Campus, Cardiology Division"}, "16947378300": {"Name": "Kornowski R.", "AuthorID": "16947378300", "AffiliationID": "60022119", "AffiliationName": "Rabin Medical Center - Beilinson Campus, Cardiology Division"}, "7003797942": {"Name": "Admon D.", "AuthorID": "7003797942", "AffiliationID": "60000087", "AffiliationName": "Hadassah Hebrew University Hospital Ein Kerem, Heart Institute"}, "16642800200": {"Name": "Kettner J.", "AuthorID": "16642800200", "AffiliationID": "60020529", "AffiliationName": "Institute for Clinical and Experimental Medicine (IKEM)"}, "7202696533": {"Name": "Otto C.", "AuthorID": "7202696533", "AffiliationID": "60006680", "AffiliationName": "Experimental Medicine Cardiovascular, Bayer AG"}, "10044490500": {"Name": "Becka M.", "AuthorID": "10044490500", "AffiliationID": "60006680", "AffiliationName": "Research and Clinical Sciences Statistics, Bayer AG"}, "36059279600": {"Name": "Kanefendt F.", "AuthorID": "36059279600", "AffiliationID": "60006680", "AffiliationName": "Clinical Pharmacokinetics, Bayer AG"}, "7004489384": {"Name": "Romo A.I.", "AuthorID": "7004489384", "AffiliationID": "116423220", "AffiliationName": "Hospital Alvaro Cunqueiro, Servicio de la Cardiologia"}, "13807322900": {"Name": "Hasin T.", "AuthorID": "13807322900", "AffiliationID": "60022846", "AffiliationName": "Shaare Zedek Medical Center, Department of Cardiology"}, "6603172686": {"Name": "Ostadal P.", "AuthorID": "6603172686", "AffiliationID": "60010760", "AffiliationName": "Na Homolce Hospital"}, "57216611909": {"Name": "Rojas G.C.", "AuthorID": "57216611909", "AffiliationID": "60030315", "AffiliationName": "Hospital Clinic de Barcelona"}, "7003359867": {"Name": "Senni M.", "AuthorID": "7003359867", "AffiliationID": "60138561", "AffiliationName": "Division of Cardiology, Cardiovascular Department, Papa Giovanni XXIII Hospital"}, "57195106892": {"Name": "Podpera I.", "AuthorID": "57195106892", "AffiliationID": null, "AffiliationName": null}, "57204881234": {"Name": "Linkova H.", "AuthorID": "57204881234", "AffiliationID": null, "AffiliationName": null}, "57193207937": {"Name": "Hajek P.", "AuthorID": "57193207937", "AffiliationID": null, "AffiliationName": null}, "7004626054": {"Name": "Bauersachs J.", "AuthorID": "7004626054", "AffiliationID": null, "AffiliationName": null}, "57192655142": {"Name": "Menck N.", "AuthorID": "57192655142", "AffiliationID": null, "AffiliationName": null}, "57216622497": {"Name": "Fuisting J.", "AuthorID": "57216622497", "AffiliationID": null, "AffiliationName": null}, "57205665712": {"Name": "Oumbe Tiam S.", "AuthorID": "57205665712", "AffiliationID": null, "AffiliationName": null}, "6603950545": {"Name": "Martinez Selles M.", "AuthorID": "6603950545", "AffiliationID": null, "AffiliationName": null}, "6506102264": {"Name": "Miro Palau V.", "AuthorID": "6506102264", "AffiliationID": null, "AffiliationName": null}, "57216618358": {"Name": "Roque M.", "AuthorID": "57216618358", "AffiliationID": null, "AffiliationName": null}, "13907649300": {"Name": "Ibanez B.", "AuthorID": "13907649300", "AffiliationID": null, "AffiliationName": null}, "14630113000": {"Name": "Arbel Y.", "AuthorID": "14630113000", "AffiliationID": null, "AffiliationName": null}, "7007129339": {"Name": "Nikolsky E.", "AuthorID": "7007129339", "AffiliationID": null, "AffiliationName": null}, "7003334288": {"Name": "Nodari S.", "AuthorID": "7003334288", "AffiliationID": null, "AffiliationName": null}, "57216611067": {"Name": "Silvio Marenzi G.C.", "AuthorID": "57216611067", "AffiliationID": null, "AffiliationName": null}, "6603658561": {"Name": "Achilli F.", "AuthorID": "6603658561", "AffiliationID": null, "AffiliationName": null}, "7004906647": {"Name": "Reimers B.", "AuthorID": "7004906647", "AffiliationID": null, "AffiliationName": null}, "null": {"Name": null, "AuthorID": null, "AffiliationID": null, "AffiliationName": null}}}